EurekAlert! -
12 Apr 2014 06:00
(European Association for the Study of the Liver) Data from a late-breaking abstract presented at the International Liver Congress 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus activity in cells at several points in the virus' lifecycle.
Share this Article